Name: UMIN ID:
Unique ID issued by UMIN | C000000068 |
---|---|
Receipt number | R000000113 |
Scientific Title | Phase II study of ABV with increased dose of adriamycin (ADM) and deleted DTIC followed by adjuvant involved-field radiotherapy (ABV/IFRT) to residual or initial bulky tumor for the previously untreated patients with advanced Hodgkin's disease (stage IB, IIB, III, IV or bulky). (JCOG9705) |
Date of disclosure of the study information | 2005/08/18 |
Last modified on | 2014/02/21 14:02:47 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2005/08/18 19:06:29 | ||
2 | Update | 2005/08/30 18:14:54 | Public title Acronym |
|
3 | Update | 2007/01/10 14:40:47 | Email1 |
|
4 | Update | 2008/08/08 11:56:35 | Email1 |
|
5 | Update | 2014/02/21 14:02:47 | Publication of results URL related to results and publications Results Results |